Roche

Companies Roche

Products Roche

Gene expression analysis and genomic variation detection

Like all LightCycler® Instruments, the LightCycler® Nano produces high quality qPCR, genotyping and high resolution melting data using easy-fit reagents, reaction vessels and instrumentation more

LightCycler® Real-Time PCR Systems for EHEC identification

Fast, reliable detection of the EHEC bacterium is essential for monitoring and controlling EHEC infections. The most appropriate targets for the rapid more

News Roche

• SynenTec To Take Over Roche Cellavista System

  Roche and SynenTec announced that Roche will transfer its Cellavista business to SynenTec, the German company which is the original inventor of the Cellavista System. This agreement was made as a result of the Roche Applied Science decision to focus its business, and guarantees future optimal suppor more

• FDA clears Roche's vitamin D laboratory test

  Roche announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for a fully automated vitamin D test for use on cobas modular platforms, further expanding the company’s bone metabolism test menu. Vitamin D is an important building block for human health and is mainly more

• Flu fighters

  Savira pharmaceuticals GmbH, a spin-off of the European Molecular Biology Laboratory (EMBL), has signed a collaboration and license agreement with Roche, thus further strengthening the links between fundamental research and major pharmaceutical development companies.This partnership should promote t more

White papers Roche

• Cannabis genome sequenced with 454 GS FLX+ System
  

  Medicinal Genomics sequenced the entire genomes of Cannabis sativa and Cannabis indica, two strains of the therapeutic plant. These largest known Cannabis genome assemblies comprise over 131 billion bases of sequence and will advance research on the therapeutic benefits of Cannabis for a wide range of health conditions, including cancer and inflammatory diseases more

• Effects of Passage Number on Cell Line Transfection
  

  An important factor in the success of any transfection experiment is the quality of the cells. As a key experimental component, the cell line can be the factor with the highest variability, affecting the reliability and reproducibility of results. more

• Enabling Cancer Research with FuGENE® HD Transfection Reagent
  

  A major problem in some areas of cancer research is the difficulty of transfecting a significant number of the cells of interest, while minimizing the cytotoxic or other off-target effects of the transfection event itself. It is well-known that the use of some transfection reagents results in high levels of expression of the gene of interest in surviving cells, but also in high levels of cell death or other cellular alterations. FuGENE® HD Transfection Reagent overcomes these problems, results in high ­levels of transfection in many cancer cell lines, and thus enables researchers to conduct experiments that have previously not been possible. more

Publications Roche

• Clinical Pharmacology KNowledge, Opportunities and Working Strengths (CPKNOWS): A Competency Model for Pursuit of Excellence in Clinical Pharmacology

  A competency model for planning and monitoring Clinical Pharmacology staff development is presented. The method provides a means to objectively define, and monitor development of key skills and knowledge areas required to fulfill the role of Clinical Pharmacologist as practiced at Roche. Skills cr more

• Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis

  Nature Genetics 45, 172 (2013). doi:10.1038/ng.2517 Authors: Philip Supply, Michael Marceau, Sophie Mangenot, David Roche, Carine Rouanet, Varun Khanna, Laleh Majlessi, Alexis Criscuolo, Julien Tap, Alexandre Pawlik, Laurence Fiette, Mickael Orgeur, Michel Fabre, Cécile Parmentier, more

• STAR: ultrafast universal RNA-seq aligner

  Motivation: Accurate alignment of high-throughput RNA-seq data is a challenging and yet unsolved problem because of the non-contiguous transcript structure, relatively short read lengths and constantly increasing throughput of the sequencing technologies. Currently available RNA-seq aligners suffer more

Market studies Roche

• Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020

  Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more

• Global Human Growth Hormone Drugs Market 2011-2015

  TechNavio’s analysts forecast the Global Human Growth Hormone Drug market to grow at a CAGR of 3 percent over the period 2011–2015. One of the key factors contributing to this market growth is the increase in number of people suffering from growth hormone deficiency. The Global Human Growth Hormone more

• Healthcare, Regulatory and Reimbursement Landscape - US

  Introduction Industry analysis specialist GlobalData, has released its new report, “Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of the US. It identifies the key t more

Websites Roche